Antiangiogenic small molecules and methods of use

Details for Australian Patent Application No. 2010278738 (hide)

Owner The United States of America, as represented by the Secretary, Department of Health and Human Services

Inventors Zudaire, Enrique; Aparicio, Marta; Cuttitta, Frank

Agent Fisher Adams Kelly

Pub. Number AU-A-2010278738

PCT Pub. Number WO2011/014825

Priority 61/230,667 31.07.09 US

Filing date 30 July 2010

Wipo publication date 3 February 2011

International Classifications

A61K 31/343 (2006.01) - condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone

A61K 31/435 (2006.01) - having six-membered rings with one nitrogen as the only ring hetero atom

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

16 February 2012 PCT application entered the National Phase

  PCT publication WO2011/014825 Priority application(s): WO2011/014825

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010278751-Cell culture medium for ADAMTS protein expression

2010278737-Use of collagen type VII for maintaining and re-inducing osteogenic abilities of mesenchymal stem cells